In this issue we are presenting another installment of our quarterly review of dealmaking—in this case January to March 2002. Our data comes from Windhover's Strategic Transactions Database, which covers the deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
Some notes about our coverage: we limit our review to human health care (thus no animal health or agricultural transactions); to mergers and acquisitions where a definitive agreement has been...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?